“hepatitis”的搜索结果，显示 231-240 项，共有 11929 项

1. 外科 - 医生 - 妙佑医疗国际

   liver disease, Cirrhosis, Alcoholic hepatitis, Encephalopathy, Alcoholic liver disease, Gastrointestinal bleeding, Hepatic encephalopathy, Ascites, Portal ...

2. 肾病和高血压- 临床试验- 妙佑医疗国际

   Learn about clinical trials being conducted at Mayo Clinic to improve the diagnosis, care and outcomes for people with kidney conditions or hypertension.

3. 血液科- 临床试验- 妙佑医疗国际

   The objectives of this study are to analyze impact of radiation on fertility, to correlate the clinical outcome of fertility after chemotherapy and or ...

4. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

5. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the safety, maximum tolerated dose (MTD) and RP2D of ABBV-383 monotherapy for patients with RRWM and to determine ...

6. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the safety, maximum tolerated dose (MTD) and RP2D of ABBV-383 monotherapy for patients with RRWM and to determine ...

7. 血液科- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the safety, maximum tolerated dose (MTD) and RP2D of ABBV-383 monotherapy for patients with RRWM and to determine ...

8. 乳腺癌- 医生与科室- 妙佑医疗国际

   Consumer Health: What do you know about hepatitis? July 28, 2021, 01:32 p.m. CDT; Mayo Clinic research suggests women over 65 be offered hereditary cancer ...

9. 血液科- 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute ...

10. 血液科- 临床试验- 妙佑医疗国际

    Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...